C19H22FN3O3
359.4 g/mol
원료의약품위험
Enrofloxacin
CAS93106-60-6
용도 분류
원료의약품
화합물 분류
헤테로사이클
주요 용도
의약 원료
Enrofloxacin is a synthetic antibacterial compound used as an active pharmaceutical ingredient. It is characterized by a quinolone core structure with fluorine and piperazine substituents, contributing to its physicochemical properties such as moderate lipophilicity and limited aqueous solubility.
manufacturing of veterinary pharmaceutical formulationsraw material for solubility-enhanced salt forms
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 93106-60-6
관련 화합물
강한 관련동일 모체 구조
1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid--hydrogen chloride (1/1)
CAS112732-17-9
active pharmaceutical ingredient
유사구조 유사유사도 0.73
1-cyclopropyl-6-fluoro-7-(4-nitrosopiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
CAS864443-44-7
antibacterial impurity standard
참고동일 카테고리
Ciprofloxacin Hydrochloride Anhydrous
CAS93107-08-5
active pharmaceutical ingredient
참고동일 카테고리
2-(4-methanesulfonylphenyl)oxirane
CAS93114-06-8
Active pharmaceutical ingredient intermediate
참고동일 카테고리
TACALCITOL MONOHYDRATE
CAS93129-94-3
active pharmaceutical ingredient
참고동일 카테고리
Levobetaxolol
CAS93221-48-8
beta-adrenergic receptor antagonist
참고same scaffold
Desfluorociprofloxacin
CAS93107-11-0
pharmaceutical impurity reference standard
참고same scaffold
Gatifloxacin sesquihydrate
CAS180200-66-2
fluoroquinolone antibiotic active pharmaceutical ingredient
안전 참조
위험
H302Harmful if swallowed
H317May cause an allergic skin reaction
H334May cause allergy or asthma symptoms or breathing difficulties if inhaled
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
식별자
IUPAC 이름
1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid
InChIKey
SPFYMRJSYKOXGV-UHFFFAOYSA-N
SMILES
CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F
동의어 목록 (79)
- CFPQ
- ERFX
- Enrofloxacin (USAN/INN)
- Enrofloxacin (USP/INN)
- Enrofloxacin for system suitability, European Pharmacopoeia (EP)
- Enrofloxacin, European Pharmacopoeia (EP)
- Enrofloxacin, United States Pharmacopeia (USP)
- BAY VP 2674
- BAY Vp 2674;PD160788
- Baytril
- Baytril (TN)
- Baytril (veterinary)
- Baytril Soft Chewable Tablets
- ENROFLOXACIN 100
- ENROFLOXACIN [MART.]
- EnroMed
- EnroMed 100
- EnroPro 100
- EnroPro 22.7
- Enroflox
- Enroflox 100
- Enroflox Chewable Tablets
- Enroflox Injection for Dogs
- Enrofloxacin
- Enrofloxacin (Standard)
- Enrofloxacin CRS
- Enrofloxacin Flavored
- Enrofloxacin Flavored Tablets
- Enrofloxacin HCl
- Enrofloxacin base
- Enrofloxacin, >=98.0% (HPLC)
- Enrofloxacin, VETRANAL(TM)
- Enrofloxacine
- Enrofloxacine [French]
- Enrofloxacino
- Enrofloxacino [Spanish]
- Enrofloxacinum
- Enrofloxacinum [Latin]
- Enroquin
- Enroquin Flavored
- Enrosite
- Enrosite Flavored
- Enroxil
- Fluroxin
- Fluroxin Flavored
- Fluroxin for Dogs
- N-Ethylciprofloxacin
- Quellaxcin
- SolutionKits
- SolutionKits Enrofloxacin
- Tenotryl
- Zobuxa
- endrofloxicin